(Q28165739)

title

Primary prevention of coronary heart disease in the elderly (English)

0 references

Primary Prevention of Coronary Heart Disease in the Elderly (English)

1 reference

22 March 2024

1 reference

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

Kimberly A. Dornbrook-Lavender

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14565805

22 March 2024

John A. Pieper

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14565805

22 March 2024

Mary T. Roth

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14565805

full work available at URL

22 March 2024

language of work or name

English

0 references

publication date

November 2003

0 references

http://journals.sagepub.com/doi/pdf/10.1345/aph.1D025

1 reference

http://journals.sagepub.com/doi/full-xml/10.1345/aph.1D025

22 March 2024

1 reference

Annals of Pharmacotherapy

22 March 2024

published in

0 references

volume

37

0 references

issue

11

0 references

page(s)

1654-63

0 references

cites work

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force

21 April 2017

1 reference

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 April 2017

1 reference

Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology

21 April 2017

1 reference

AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association

21 January 2018

1 reference

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

21 January 2018

1 reference

Characteristics of patients with uncontrolled hypertension in the United States.

21 January 2018

1 reference

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 January 2018

1 reference

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

21 January 2018

1 reference

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

21 January 2018

1 reference

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

21 January 2018

1 reference

Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials

21 January 2018

1 reference

Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further analyses from the Antihypertensive and Lipid-Lowering treat

21 January 2018

1 reference

Evaluation and treatment of patients with systemic hypertension

21 January 2018

1 reference

Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program

21 January 2018

1 reference

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

Therapy with hydroxymethylglutaryl coenzyme a reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults: evidence from the Cardiovascular Health Study

21 January 2018

1 reference

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

21 January 2018

1 reference

The ALLHAT lipid lowering trial--less is less

21 January 2018

1 reference

Statin therapy in the elderly: does it make good clinical and economic sense?

21 January 2018

1 reference

Clinically relevant differences between the statins: implications for therapeutic selection

21 January 2018

1 reference

Pharmacological interactions of statins.

21 January 2018

1 reference

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction

21 January 2018

1 reference

Final report on the aspirin component of the ongoing Physicians' Health Study

21 January 2018

1 reference

Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project

21 January 2018

1 reference

Clinical practice. Aspirin for primary prevention of coronary events

21 January 2018

1 reference

Risk stratification in hypertension: new insights from the Framingham Study

21 January 2018

3

1 reference

Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group

22 March 2024

10

1 reference

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

22 March 2024

12

1 reference

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

22 March 2024

13

1 reference

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

22 March 2024

16

1 reference

Treating hypertension - what are we to believe?

22 March 2024

24

1 reference

The verdict from ALLHAT--thiazide diuretics are the preferred initial therapy for hypertension

22 March 2024

25

1 reference

Impact of cholesterol on cardiovascular morbidity and mortality in older adults

22 March 2024

27

1 reference

State-of-the-art update and review: clinical trials of lipid-lowering agents

22 March 2024

28

1 reference

Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons

22 March 2024

29

1 reference

Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study. Hypertension Optimal Treatment

22 March 2024

46

1 reference

Adverse effects of low-dose aspirin in a healthy elderly population

22 March 2024

50

1 reference

22 March 2024

Identifiers

DOI

10.1345/APH.1D025

0 references